Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1290779
Max Phase: Preclinical
Molecular Formula: C16H14N2O3S
Molecular Weight: 314.37
Molecule Type: Small molecule
Associated Items:
ID: ALA1290779
Max Phase: Preclinical
Molecular Formula: C16H14N2O3S
Molecular Weight: 314.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc2c(c1)/C(=C\c1ccc(S(N)(=O)=O)cc1)C(=O)N2
Standard InChI: InChI=1S/C16H14N2O3S/c1-10-2-7-15-13(8-10)14(16(19)18-15)9-11-3-5-12(6-4-11)22(17,20)21/h2-9H,1H3,(H,18,19)(H2,17,20,21)/b14-9+
Standard InChI Key: UNTKQXWERZKNSH-NTEUORMPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 314.37 | Molecular Weight (Monoisotopic): 314.0725 | AlogP: 2.14 | #Rotatable Bonds: 2 |
Polar Surface Area: 89.26 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.20 | CX Basic pKa: | CX LogP: 2.38 | CX LogD: 2.38 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.83 | Np Likeness Score: -0.96 |
1. Lai Y, Ma L, Huang W, Yu X, Zhang Y, Ji H, Tian J.. (2010) Synthesis and biological evaluation of 3-[4-(amino/methylsulfonyl)phenyl]methylene-indolin-2-one derivatives as novel COX-1/2 and 5-LOX inhibitors., 20 (24): [PMID:21055929] [10.1016/j.bmcl.2010.10.056] |
Source(1):